Document Detail

Selective α1-adrenoceptor antagonist (controlled release tablets) in preoperative management of pheochromocytoma.
MedLine Citation:
PMID:  21046486     Owner:  NLM     Status:  In-Process    
The objective of this article is to evaluate the efficacy of Doxazosin Mesylate Controlled Release Tablets for preoperative treatment of patients with pheochromocytoma. Between 2003 and 2008, 67 patients with confirmed diagnoses of pheochromocytoma were enrolled in this study. According to the drug used in preoperative management, patients were divided into two groups: Doxazosin Mesylate pretreatment group (n=36) and Phenoxybenzamine pretreatment group (n=31). Surgery was performed only in patients who met the optimal preoperative condition. The hematocrit decreased significantly (P<0.001) after antiadrenergic therapy in patients pretreated with phenoxybenzamine or doxazosin. There was no significant difference between the fluid intakes during operation in both groups. The systolic arterial pressures both before and after induction of anesthesia were all significantly higher in the doxazosin patients than in the phenoxybenzamine group (P<0.05). After tumor removed, the lowest systolic arterial pressure was significantly higher in doxazosin group than in phenoxybenzamine group (P<0.05). The fluctuation of systolic arterial pressure during operation was more stable in doxazosin group than in phenoxybenzamine group (P<0.05). Doxazosin mesylate controlled release tablet was as effective as phenoxybenzamine in preoperative volume expansion. Although phenoxybenzamine provided better arterial pressure control, patients pretreated with DOX experienced more stable perioperative hemodynamic changes, shorter preoperative management periods and more simple medication.
Yu Zhu; Hong-chao He; Ting-wei Su; Yu-xuan Wu; Wei-qing Wang; Ju-ping Zhao; Zhoujun Shen; Chong-yu Zhang; Wen-bin Rui; Wen-long Zhou; Fu-kang Sun; Guang Ning
Related Documents :
6369366 - Does prostacyclin prevent cognitive deficits after open heart surgery?
19333246 - The incidence and management of tolerance in intrathecal baclofen therapy.
12352176 - Modified programme of in-patient (phase i) cardiac rehabilitation after acute myocardia...
17892986 - Effects of beta-erythropoietin treatment on left ventricular remodeling, systolic funct...
18644696 - Long-term indwelling pleural catheter (pleurx) for malignant pleural effusion unsuitabl...
23009186 - Adjunctive atropine versus metoclopramide: can we reduce ketamine-associated vomiting i...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't     Date:  2010-07-18
Journal Detail:
Title:  Endocrine     Volume:  38     ISSN:  1559-0100     ISO Abbreviation:  Endocrine     Publication Date:  2010 Oct 
Date Detail:
Created Date:  2010-11-03     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9434444     Medline TA:  Endocrine     Country:  United States    
Other Details:
Languages:  eng     Pagination:  254-9     Citation Subset:  IM    
Department of Urology, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, 200025, China.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Exposing cultured mouse ovarian follicles under increased gonadotropin tonus to aromatizable androge...
Next Document:  The use of a stringent selection system allows the identification of DNA elements that augment gene ...